Literature DB >> 16361649

Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line.

Axel Grothey, Daniel Sargent.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16361649     DOI: 10.1200/JCO.2005.04.4792

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  69 in total

1.  [Response prediction--early response evaluation. Consequences for surgical oncology].

Authors:  J R Siewert; F Lordick
Journal:  Chirurg       Date:  2006-12       Impact factor: 0.955

2.  Section III: Treatment of Advanced Gastrointestinal Cancers.

Authors:  Howard S Hochster; Eileen M O'Reilly; Jaffer A Ajani; Alan P Venook
Journal:  Gastrointest Cancer Res       Date:  2007-11

3.  Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B).

Authors:  Vincenzo Formica; Vittore Cereda; Maria-Giovana di Bari; Italia Grenga; Manfredi Tesauro; Palmirotta Raffaele; Patrizia Ferroni; Fiorella Guadagni; Mario Roselli
Journal:  Med Oncol       Date:  2013-10-11       Impact factor: 3.064

4.  A long-term survival case of rectal cancer with multiple pulmonary metastases treated with multidisciplinary chemotherapy.

Authors:  Hiroyuki Ando; Yoshinori Shitara; Yasushi Mogami; Tsutomu Kobayashi; Toshiki Yajima; Masachika Tani; Nobuhiro Morinaga; Masatoshi Ishizaki; Shinji Hashimoto; Toshihiro Nakabayashi; Hiroyuki Kuwano
Journal:  Int Surg       Date:  2013 Oct-Dec

Review 5.  New approaches in angiogenic targeting for colorectal cancer.

Authors:  Aleix Prat; Esther Casado; Javier Cortés
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

Review 6.  Extravascular use of drug-eluting beads: a promising approach in compartment-based tumor therapy.

Authors:  Simon Binder; Andrew L Lewis; J-Matthias Löhr; Michael Keese
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 7.  The role of targeted therapy in the treatment of advanced colorectal cancer.

Authors:  Marwan Fakih
Journal:  Curr Treat Options Oncol       Date:  2009-02-24

Review 8.  Epidemiology and management options for colorectal cancer in children.

Authors:  Raya Saab; Wayne L Furman
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

9.  Impact of Metastasectomy in the Multimodality Approach for BRAF V600E Metastatic Colorectal Cancer: The Mayo Clinic Experience.

Authors:  Benny Johnson; Zhaohui Jin; Mark J Truty; Rory L Smoot; David M Nagorney; Michael L Kendrick; Benjamin R Kipp; Axel Grothey
Journal:  Oncologist       Date:  2017-09-13

10.  Association between COX-2 expression and effectiveness of COX-2 inhibitors in a phase II trial in patients with metastatic colorectal adenocarcinoma.

Authors:  Khaldoun Almhanna; Bassel El-Rayes; Seema Sethi; Gregory Dyson; Lance Heilbrun; Philip A Philip; Fazlul Sarkar
Journal:  Anticancer Res       Date:  2012-08       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.